glp-1 weight loss drug market news today Size, Share Lilly's new GLP-1 pill is

Head-to-head efficacy comparison Retatrutide versus semaglutide is not even close in terms of raw weight loss numbers

Despite the potential for side effects, few physicians think that side effects will be a barrier to wider GLP-1RA adoption

Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications primarily used to manage type 2 diabetes and, in some formulations, to support weight management

Determining whether this conceptual advantage translates into clinical benefit will require prospective trials specifically designed to assess cognitive and neurodegenerative outcomes

Gastric emptying was delayed, similarly to the effect observed under therapy with GLP-1RA (61)

Additionally, production and supply constraints, including high manufacturing costs and limited scalability, pose significant barriers